All Stories

  1. Evaluation of Androgen Receptor in Relation to Estrogen Receptor (AR/ER) and Progesterone Receptor (AR/PgR): A New Must in Breast Cancer?
  2. Sorafenib for the treatment of breast cancer
  3. Progress with palbociclib in breast cancer: latest evidence and clinical considerations
  4. Androgen receptor signaling pathways as a target for breast cancer treatment